- Home
- SPE vs THTX Comparison
SPE vs THTX Comparison
Compare SPE & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPE
- THTX
- Stock Information
- Founded
- SPE 1993
- THTX 1993
- Country
- SPE United States
- THTX Canada
- Employees
- SPE N/A
- THTX N/A
- Industry
- SPE Finance/Investors Services
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- SPE Finance
- THTX Health Care
- Exchange
- SPE Nasdaq
- THTX Nasdaq
- Market Cap
- SPE 166.0M
- THTX 144.8M
- IPO Year
- SPE N/A
- THTX N/A
- Fundamental
- Price
- SPE $15.78
- THTX $3.29
- Analyst Decision
- SPE
- THTX Hold
- Analyst Count
- SPE 0
- THTX 1
- Target Price
- SPE N/A
- THTX N/A
- AVG Volume (30 Days)
- SPE 25.4K
- THTX 372.3K
- Earning Date
- SPE 01-01-0001
- THTX 10-09-2025
- Dividend Yield
- SPE 8.55%
- THTX N/A
- EPS Growth
- SPE N/A
- THTX N/A
- EPS
- SPE N/A
- THTX N/A
- Revenue
- SPE N/A
- THTX $84,378,000.00
- Revenue This Year
- SPE N/A
- THTX N/A
- Revenue Next Year
- SPE N/A
- THTX $13.76
- P/E Ratio
- SPE N/A
- THTX N/A
- Revenue Growth
- SPE N/A
- THTX 2.19
- 52 Week Low
- SPE $10.26
- THTX $1.12
- 52 Week High
- SPE $12.59
- THTX $3.31
- Technical
- Relative Strength Index (RSI)
- SPE 58.90
- THTX 70.36
- Support Level
- SPE $15.33
- THTX $3.26
- Resistance Level
- SPE $15.69
- THTX $3.31
- Average True Range (ATR)
- SPE 0.10
- THTX 0.02
- MACD
- SPE 0.02
- THTX -0.00
- Stochastic Oscillator
- SPE 56.84
- THTX 71.43
About SPE Special Opportunities Fund Inc
Special Opportunities Fund Inc is a closed-ended diversified management investment company. Its investment objective is to have the total return. The company's investment portfolio consists of investment companies, common stocks, money market funds, commodity partnerships, preferred stocks, convertible bonds, liquidating trusts, promissory notes, senior unsecured notes, warrants, rights, corporate notes and corporate bonds. In addition, it also makes investments in construction materials, consumer finance, healthcare equipment and supplies, independent power and renewable electricity producers, insurance, personal products, professional services and real estate investment trusts.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.